Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-04

Clinical Trial Update: To Evaluate Efficacy of Monotherapy of Oxcarbazepine Versus Combination of Gabapentin With Oxcarbazepine in the Management of Trigeminal Neuralgia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing oxcarbazepine monotherapy to a gabapentin-oxcarbazepine combination for trigeminal neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • Oxcarbazepine (Oxcarbazepine)

Snippet

Sponsor: Rehman Medical Institute - RMI | Conditions: Effectiveness of Drugs Was Compared for Treating Trigeminal Neuralgia, Pain | Phase 2, Phase 3 | Status: COMPLETED